Home / Companies / News / Serum Institute to increase Covishield production next month

Serum Institute to increase Covishield production next month

Pune: Police personnel guard during the transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, (PTI) — Pune: Police personnel guard during the transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, **(PTI)**

1 min read . Updated: 31 May 2021, 11:28 AM IST Staff Writer

This came amid reports of shortage of Covid-19 vaccines in the country as flagged by several state governments.

The Serum Institute of India will raise production of the AstraZeneca COVID-19 vaccine to about 90 million doses in June from about 65 million a month now, a company spokesman told Reuters on Monday.

This came amid reports of shortage of COVID-19 vaccines in the country as flagged by several state governments.

MINT PREMIUM See All

Russian President Vladimir Putin says West wants to make Russia a colony

Premium

RBI admits it will miss inflation target but remains ov ...

India is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- for its COVID-19 vaccination programme. Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for emergency use. (A